Biotech · San Francisco, CA · Founded 2024 · Privately Held (backing)
Developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. Chai Discovery is based in San Francisco, CA and was founded in 2024. Its last reported valuation was $1.3 billion in Dec 2025. It has raised $230 million across 4 recorded rounds; the latest was a $400 million Series C in Jul 2026.
Last reported valuation
$1.3B
Oct 2026
Priced at
—
Total raised
$230.0M
Last round
Series C
Jul 2026
Cap table — not yet on record
Chai Discovery's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Chai Discovery with a free account
·The complete investor list: 21 names
·Watch Chai Discovery: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Chai Discovery's 4 recorded funding rounds.